Status:

RECRUITING

Evaluation of the Safety and Performance of the Neocement® Inject P

Lead Sponsor:

Bioceramed

Collaborating Sponsors:

Local Health Unit Barcelos/Esposende, Public Health Unit

Conditions:

Bone Defects

Orthopaedic Surgery (30 Minutes or Longer)

Eligibility:

All Genders

18+ years

Brief Summary

This study aims to collect real-world clinical data to gather information on the performance and safety of the Neocement® Inject P when used according to its intended purpose and current clinical appl...

Detailed Description

Neocement® Inject P represents a breakthrough in orthopaedic biomaterials, meticulously engineered to enhance bone repair and regeneration. This synthetic bone substitute combines tetracalcium phospha...

Eligibility Criteria

Inclusion

  • Adult males or females (age \> 18 years old);
  • Patients with bone defect treatment who meet predefined criteria in Instructions For Use (IFU) of Neocement® Inject P;
  • Patients who are able to sign an informed consent form (for data collection)
  • Patients with bone defects, which may be surgically created or result from traumatic injury to the bone;
  • Patients with bone skeletal defects that are not intrinsic to the stability of the bone structure or with a site that can be stabilized;

Exclusion

  • Patients who are unable to understand consent and the objectives of the study;
  • Signs of local or systemic acute/ active or chronic infections;
  • Metabolic affections;
  • Severe degenerative diseases, conditions in which general bone grafting is not advisable;
  • Implementation sites that allow product migration;
  • Conditions which require structural support in the skeletal system;
  • Conditions where the implantation site is unstable and not rigidly fixated;
  • Sensibility to the implantable materials;
  • Known hypersensitivity to the implant material.

Key Trial Info

Start Date :

September 5 2025

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

June 1 2027

Estimated Enrollment :

80 Patients enrolled

Trial Details

Trial ID

NCT06973239

Start Date

September 5 2025

End Date

June 1 2027

Last Update

October 2 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Unidade Local de Saúde Esposende/Barcelos

Barcelos, Portugal